Specific IgE antibodies to Bordetella pertussis after immunisation in infancy. 1988

M Haus, and E G Weinberg, and D Malherbe

UI MeSH Term Description Entries
D007073 Immunoglobulin E An immunoglobulin associated with MAST CELLS. Overexpression has been associated with allergic hypersensitivity (HYPERSENSITIVITY, IMMEDIATE). IgE
D007115 Immunization Schedule Schedule giving optimum times usually for primary and/or secondary immunization. Immunization Schedules,Schedule, Immunization,Schedules, Immunization
D007223 Infant A child between 1 and 23 months of age. Infants
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D010567 Pertussis Vaccine A suspension of killed Bordetella pertussis organisms, used for immunization against pertussis (WHOOPING COUGH). It is generally used in a mixture with diphtheria and tetanus toxoids (DTP). There is an acellular pertussis vaccine prepared from the purified antigenic components of Bordetella pertussis, which causes fewer adverse reactions than whole-cell vaccine and, like the whole-cell vaccine, is generally used in a mixture with diphtheria and tetanus toxoids. (From Dorland, 28th ed) Vaccine, Pertussis
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D001886 Bordetella pertussis A species of gram-negative, aerobic bacteria that is the causative agent of WHOOPING COUGH. Its cells are minute coccobacilli that are surrounded by a slime sheath. Bacterium tussis-convulsivae,Haemophilus pertussis,Hemophilus pertussis
D004168 Diphtheria Toxoid The formaldehyde-inactivated toxin of Corynebacterium diphtheriae. It is generally used in mixtures with TETANUS TOXOID and PERTUSSIS VACCINE; (DTP); or with tetanus toxoid alone (DT for pediatric use and Td, which contains 5- to 10-fold less diphtheria toxoid, for other use). Diphtheria toxoid is used for the prevention of diphtheria; DIPHTHERIA ANTITOXIN is for treatment. Diphtheria Vaccine,Toxoid, Diphtheria,Vaccine, Diphtheria
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies

Related Publications

M Haus, and E G Weinberg, and D Malherbe
May 1988, Lancet (London, England),
M Haus, and E G Weinberg, and D Malherbe
April 1989, Lancet (London, England),
M Haus, and E G Weinberg, and D Malherbe
August 2005, Epidemiology and infection,
M Haus, and E G Weinberg, and D Malherbe
September 1985, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
M Haus, and E G Weinberg, and D Malherbe
September 1987, Zhurnal mikrobiologii, epidemiologii i immunobiologii,
M Haus, and E G Weinberg, and D Malherbe
July 2006, Expert opinion on biological therapy,
M Haus, and E G Weinberg, and D Malherbe
April 2006, Vaccine,
M Haus, and E G Weinberg, and D Malherbe
July 1990, Journal of medical microbiology,
M Haus, and E G Weinberg, and D Malherbe
December 1999, European journal of pediatrics,
Copied contents to your clipboard!